Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process

被引:22
作者
Dhillon, Kuldeep S. [1 ]
Bhandal, Ajit S. [1 ]
Aznar, Constantino P. [1 ]
Lorey, Fred W. [1 ]
Neogi, Partha [1 ]
机构
[1] Calif Dept Publ Hlth, Genet Dis Lab Branch, Richmond, CA 94804 USA
关键词
Tandem mass spectrometry; Genetic disease screening; Tyrosinemia type I; Succinylacetone; Newborn screening; Dried blood spot; DRIED BLOOD SPOTS; SUCCINYLACETONE;
D O I
10.1016/j.cca.2010.12.028
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Succinylacetone (SUAC). a specific marker for tyrosinemia type I (Tyr I) cannot be detected by the routine LC-MS/MS screening of amino acids (AA) and acylcarnitines (AC) in newborns. The current derivatized methods require double extraction of newborn dried blood spots (DBS); one for AA and AC and the second for SUAC from the blood spot left after the first extraction. We have developed a method in which AA, AC and SUAC are extracted in a single extraction resulting in significant reduction in labor and assay time. Methods: The 3.2 mm DBS were extracted by incubating at 45 degrees C for 45 min with 100 mu l of acetonitrile (ACN)-water-formic acid mixture containing hydrazine and stable-isotope labeled internal standards of AA, AC and SUAC. The extract was derivatized with n-butanolic-HCl and analyzed by LC-MS/MS. Results: The average inter-assay CVs for. AA, AC and SUAC were 10.1. 10.8 and 7.1% respectively. The extraction of analytes with ACN-water mixture showed no significant difference in their recovery compared to commonly used solvent MeOH. The concentration of hydrazine had considerable impact on SUAC extraction. Conclusion: We developed a new MS/MS derivatized method to detect AA/AC/ SUAC in a single extraction process for screening Tyr I along with disorders of AA and AC. Published by Elsevier B.V.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 13 条
  • [1] Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots
    Allard, P
    Grenier, A
    Korson, MS
    Zytkovicz, TH
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (11) : 1010 - 1015
  • [2] Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns
    Chace, DH
    Kalas, TA
    Naylor, EW
    [J]. CLINICAL CHEMISTRY, 2003, 49 (11) : 1797 - 1817
  • [3] Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters
    Chace, Donald H.
    Lim, Timothy
    Hansen, Christina R.
    De Jesus, Victor R.
    Hannon, W. Harry
    [J]. CLINICA CHIMICA ACTA, 2009, 407 (1-2) : 6 - 9
  • [4] Holme E, 2000, Clin Liver Dis, V4, P805, DOI 10.1016/S1089-3261(05)70142-2
  • [5] Holme Elisabeth, 1995, Current Opinion in Pediatrics, V7, P726
  • [6] TRYOSINAEMIA TYPE-I - AN UPDATE
    KVITTINGEN, EA
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (04) : 554 - 562
  • [7] The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs
    la Marca, Giancarlo
    Malvagia, Sabrina
    Pasquini, Elisabetta
    Innocenti, Marzia
    Fernandez, Maira Rebollido
    Donati, Maria Alice
    Zammarchi, Enrico
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2008, 22 (06) : 812 - 818
  • [8] LABERGE C, 1969, AM J HUM GENET, V21, P36
  • [9] Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I
    Magera, MJ
    Gunawardena, ND
    Hahn, SH
    Tortorelli, S
    Mitchell, GA
    Goodman, SI
    Rinaldo, P
    Matern, D
    [J]. MOLECULAR GENETICS AND METABOLISM, 2006, 88 (01) : 16 - 21
  • [10] Mitchell G.A., 2001, METABOLIC MOL BASES, V8th, P1777